Ship Healthcare Holdings Toekomstige groei
Future criteriumcontroles 3/6
Ship Healthcare Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 9.3% en 5.3% per jaar. De winst per aandeel zal naar verwachting groeien met 9.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 10.5% zijn.
Belangrijke informatie
9.3%
Groei van de winst
9.3%
Groei van de winst per aandeel
Healthcare winstgroei | 8.4% |
Inkomstengroei | 5.3% |
Toekomstig rendement op eigen vermogen | 10.5% |
Dekking van analisten | Low |
Laatst bijgewerkt | 08 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
These 4 Measures Indicate That Ship Healthcare Holdings (TSE:3360) Is Using Debt Safely
Oct 10Investors Still Waiting For A Pull Back In Ship Healthcare Holdings, Inc. (TSE:3360)
Sep 20An Intrinsic Calculation For Ship Healthcare Holdings, Inc. (TSE:3360) Suggests It's 36% Undervalued
Aug 02Here's Why Ship Healthcare Holdings (TSE:3360) Has Caught The Eye Of Investors
Jul 02We Think Ship Healthcare Holdings' (TSE:3360) Healthy Earnings Might Be Conservative
May 21Slowing Rates Of Return At Ship Healthcare Holdings (TSE:3360) Leave Little Room For Excitement
May 02Ship Healthcare Holdings' (TSE:3360) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 14Ship Healthcare Holdings (TSE:3360) Is Increasing Its Dividend To ¥48.00
Feb 27Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
3/31/2027 | 734,775 | 18,096 | 19,978 | N/A | 4 |
3/31/2026 | 701,500 | 16,951 | 19,544 | N/A | 4 |
3/31/2025 | 666,325 | 15,778 | 9,834 | N/A | 4 |
6/30/2024 | 639,740 | 13,856 | N/A | N/A | N/A |
3/31/2024 | 630,988 | 13,789 | 28,093 | 31,609 | N/A |
12/31/2023 | 618,222 | 11,837 | N/A | N/A | N/A |
9/30/2023 | 605,536 | 11,606 | 18,711 | 22,687 | N/A |
6/30/2023 | 597,538 | 13,476 | N/A | N/A | N/A |
3/31/2023 | 572,285 | 12,063 | 10,197 | 14,105 | N/A |
12/31/2022 | 558,319 | 12,639 | N/A | N/A | N/A |
9/30/2022 | 543,210 | 12,197 | 13,589 | 16,943 | N/A |
6/30/2022 | 521,352 | 12,155 | N/A | N/A | N/A |
3/31/2022 | 514,353 | 12,172 | 8,958 | 12,428 | N/A |
12/31/2021 | 510,953 | 10,432 | N/A | N/A | N/A |
9/30/2021 | 511,088 | 11,687 | 15,633 | 20,468 | N/A |
6/30/2021 | 505,916 | 12,239 | N/A | N/A | N/A |
3/31/2021 | 497,156 | 12,280 | 14,762 | 19,772 | N/A |
12/31/2020 | 475,751 | 11,750 | N/A | N/A | N/A |
9/30/2020 | 462,894 | 9,821 | 5,817 | 9,115 | N/A |
6/30/2020 | 480,845 | 11,591 | N/A | N/A | N/A |
3/31/2020 | 484,395 | 11,803 | 20,198 | 24,010 | N/A |
12/31/2019 | 484,940 | 13,513 | N/A | N/A | N/A |
9/30/2019 | 484,134 | 13,935 | 19,595 | 24,423 | N/A |
6/30/2019 | 454,473 | 11,319 | N/A | N/A | N/A |
3/31/2019 | 444,048 | 11,236 | 7,515 | 10,534 | N/A |
12/31/2018 | 441,663 | 9,954 | N/A | N/A | N/A |
9/30/2018 | 440,256 | 10,719 | 11,169 | 13,026 | N/A |
6/30/2018 | 434,422 | 10,603 | N/A | N/A | N/A |
3/31/2018 | 425,566 | 10,350 | N/A | 20,204 | N/A |
12/31/2017 | 425,521 | 11,164 | N/A | N/A | N/A |
9/30/2017 | 408,393 | 9,880 | N/A | 18,413 | N/A |
6/30/2017 | 408,771 | 10,071 | N/A | N/A | N/A |
3/31/2017 | 408,487 | 9,410 | N/A | 15,311 | N/A |
12/31/2016 | 379,940 | 9,634 | N/A | N/A | N/A |
9/30/2016 | 360,683 | 9,292 | N/A | 16,786 | N/A |
6/30/2016 | 331,101 | 8,553 | N/A | N/A | N/A |
3/31/2016 | 306,853 | 8,847 | N/A | 16,708 | N/A |
12/31/2015 | 297,560 | 7,406 | N/A | N/A | N/A |
9/30/2015 | 281,691 | 6,989 | N/A | 11,266 | N/A |
6/30/2015 | 287,015 | 8,054 | N/A | N/A | N/A |
3/31/2015 | 273,327 | 7,472 | N/A | 1,682 | N/A |
12/31/2014 | 277,924 | 8,462 | N/A | N/A | N/A |
9/30/2014 | 274,959 | 8,742 | N/A | 8,273 | N/A |
6/30/2014 | 255,363 | 7,496 | N/A | N/A | N/A |
3/31/2014 | 259,189 | 8,523 | N/A | 13,796 | N/A |
12/31/2013 | 231,571 | 7,382 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 3360 ( 9.3% per jaar) ligt boven de spaarquote ( 0.3% ).
Winst versus markt: De winst van 3360 ( 9.3% per jaar) zal naar verwachting sneller groeien dan de JP markt ( 9.1% per jaar).
Hoge groeiwinsten: De winst van 3360 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 3360 ( 5.3% per jaar) zal naar verwachting sneller groeien dan de markt JP ( 4.2% per jaar).
Hoge groei-inkomsten: De omzet van 3360 ( 5.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 3360 zal naar verwachting over 3 jaar laag zijn ( 10.5 %).